MedPath

insulin

Generic Name
insulin

Mechanisms for Restoration of Hypoglycemia Awareness

Early Phase 1
Completed
Conditions
Type1 Diabetes Mellitus
Interventions
Device: Continuous Glucose Monitor (CGM)
First Posted Date
2018-11-13
Last Posted Date
2025-02-12
Lead Sponsor
Yale University
Target Recruit Count
55
Registration Number
NCT03738852
Locations
🇺🇸

Yale Center for Clinical Investigation (YCCI) Church Street Research Unit (CSRU), New Haven, Connecticut, United States

Observational Study of Drug Naive Diabetes Receiving Insulin Therapy

Conditions
Type 2 Diabetes
Interventions
First Posted Date
2018-10-18
Last Posted Date
2018-10-18
Lead Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Target Recruit Count
150
Registration Number
NCT03710811
Locations
🇨🇳

at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University, Nanjing, Jiangsu, China

🇨🇳

Zhejiang Provincial People'S Hospital, Hangzhou, Zhejiang, China

Insulin Treatment in Diabetic Older People With Heart Failure.

Phase 2
Terminated
Conditions
Heart Failure
Diabetes Mellitus, Type 2
Interventions
First Posted Date
2018-09-11
Last Posted Date
2019-11-18
Lead Sponsor
Mario Negri Institute for Pharmacological Research
Target Recruit Count
10
Registration Number
NCT03665350
Locations
🇮🇹

Ospedale Bolognini di Seriate, Seriate, BG, Italy

🇮🇹

Ospedale di Passirana, Passirana, MI, Italy

🇮🇹

Ospedale Treviglio, Treviglio, BG, Italy

Tight Versus Liberal Blood Glucose Control in Adult Critically Ill Patients

Phase 3
Active, not recruiting
Conditions
Hyperglycemia
Critical Illness
Interventions
First Posted Date
2018-09-11
Last Posted Date
2023-06-05
Lead Sponsor
KU Leuven
Target Recruit Count
9230
Registration Number
NCT03665207
Locations
🇧🇪

Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium

🇧🇪

Department of Intensive Care Medicine, Jessa Hospital Hasselt, Hasselt, Belgium

🇧🇪

Department of Intensive Care Medicine, University Hospitals Leuven, Leuven, Belgium

and more 1 locations

Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes Mellitus

Phase 3
Terminated
Conditions
Gestational Diabetes
Interventions
First Posted Date
2018-08-29
Last Posted Date
2020-07-24
Lead Sponsor
Women and Infants Hospital of Rhode Island
Target Recruit Count
1
Registration Number
NCT03651531
Locations
🇺🇸

Women & Infants Hospital, Providence, Rhode Island, United States

Diabetes in Pregnancy and Pregnancy Outcomes

Completed
Conditions
Diabetes Mellitus in Pregnancy
Diabetes, Gestational
Interventions
Dietary Supplement: Medical Nutrition Therapy
Drug: Oral Antidiabetics
First Posted Date
2018-07-27
Last Posted Date
2018-07-27
Lead Sponsor
Tarumanagara University
Target Recruit Count
45
Registration Number
NCT03602846

Gestational Diabetes and Pharmacotherapy (GAP)

Phase 4
Recruiting
Conditions
Gestational Diabetes
Interventions
First Posted Date
2018-05-17
Last Posted Date
2025-01-03
Lead Sponsor
Medical College of Wisconsin
Target Recruit Count
416
Registration Number
NCT03527537
Locations
🇺🇸

Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults

Early Phase 1
Completed
Conditions
Vascular Stiffness
Insulin Sensitivity
Interventions
Drug: Dextrose 20% solution
First Posted Date
2018-05-09
Last Posted Date
2022-05-13
Lead Sponsor
University of Virginia
Target Recruit Count
15
Registration Number
NCT03520569
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Metformin Plus Insulin on Non-obese Autoimmune Diabetes

Phase 4
Conditions
Type 1 Diabetes Mellitus
Autoimmune Diabetes
Interventions
First Posted Date
2018-05-02
Last Posted Date
2020-03-18
Lead Sponsor
Second Xiangya Hospital of Central South University
Target Recruit Count
15
Registration Number
NCT03513874
Locations
🇨🇳

Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China

Intensive Versus Conventional Hyperglycemic Control in Hospitalized Non-critically Ill Patients

Not Applicable
Recruiting
Conditions
Non-critically Ill Patients
Diabetes Mellitus
Interventions
First Posted Date
2018-04-27
Last Posted Date
2024-04-11
Lead Sponsor
Rabin Medical Center
Target Recruit Count
600
Registration Number
NCT03510078
Locations
🇮🇱

Rambam Medical Center, Haifa, Israel

🇮🇱

Rabin Medical Center, Petah Tikva, Israel

© Copyright 2025. All Rights Reserved by MedPath